Stay updated on Nivolumab in Resected Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Resected Esophageal Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T18:29:11.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    A general notice about NIH’s terminology transition appears above the blocked study record, and the site revision number is updated.
    Difference
    1%
    Check dated 2026-10-20T19:07:59.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:51:02.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The 403 Forbidden content was removed and the study details page now loads normally. This restores access to the study record and related navigation for users.
    Difference
    0.5%
    Check dated 2026-09-29T19:31:22.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record NCT02743494, replacing the expected trial details with an access-restricted screen. This indicates restricted access or a site-side block preventing display of the core content.
    Difference
    17%
    Check dated 2026-09-22T21:50:45.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.6 to v3.7.0, signaling an update to the page template or rendering. This appears to be a surface-level change affecting presentation, not the underlying study content.
    Difference
    0.0%
    Check dated 2026-09-15T22:05:42.000Z thumbnail image

Stay in the know with updates to Nivolumab in Resected Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Resected Esophageal Cancer Clinical Trial page.